GlassScriptPhysician profile
Jessica Starr
NPI 1275850208
$3,597.45
in general payments reported to CMS, 2019-2025
15 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.51 · 2020: $43.30 · 2021: $339 · 2022: $338 · 2023: $1,168 · 2024: $891 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,814.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $645.95 | 2020-2025 | Evenity, Prolia, Tepezza |
| Lilly USA, LLC | $592.80 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Radius Health, INC. | $508.38 | 2023-2025 | Tymlos, Binosto |
| Novo Nordisk INC | $425.71 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $289.44 | 2021-2024 | |
| Astellas Pharma US INC | $239.93 | 2023-2024 | Veozah |
| Alvogen INC | $237.70 | 2023-2025 | Teriparatide |
| Alexion Pharmaceuticals, INC. | $183.25 | 2019-2025 | Strensiq |
| Kyowa Kirin, INC. | $158.60 | 2023-2025 | Crysvita |
| Avion Pharmaceuticals | $108.14 | 2021-2023 | Divigel |
| Corcept Therapeutics | $69.03 | 2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $56.59 | 2025 | Yorvipath |
| Boston Scientific Corporation | $41.39 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $24.14 | 2025 | |
| Merck Sharp & Dohme LLC | $16.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Starr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.